Helena Bioinformatics
About Helena Bioinformatics
Helena Bioinformatics is a healthcare AI company based in Sofia, Bulgaria, specializing in software for genomic variant interpretation and biomedical literature discovery. Their flagship product, Folklore Clinical Variant Interpretation, streamlines the process for qualified genetics professionals by providing variant annotation, automated ACMG/AMP classification, source-linked evidence, and comprehensive reporting. This system is designed to transform raw genomic data into actionable clinical insights, supporting professional review rather than autonomous diagnostic or treatment decisions.
Complementing Folklore is Noodle Biomedical Literature Discovery, a tool that facilitates publication searches and explores citation and semantic connections between scientific papers. Both products are designed to assist research and laboratory teams in navigating genomic findings and the extensive literature that informs their review. Helena Bioinformatics emphasizes building secure, auditable infrastructure for clinical genomics, with AI operating within a controlled environment and processing sensitive genomic information on European infrastructure.
For physicians, Helena Bioinformatics’ offerings aim to enhance the efficiency and accuracy of genomic interpretation in clinical practice. The Folklore platform integrates various crucial pieces of information—annotation, deterministic classification, phenotype, inheritance, and literature evidence—into a single case record for specialist review. This approach is particularly valuable for medical genetics laboratories and rare-disease teams, enabling them to process and interpret whole-exome (WES) or whole-genome sequencing (WGS) cases more effectively. The company also focuses on developing methodologies for deterministic variant classification, structural variation, and agentic interpretation, contributing to the scientific understanding of how genomic evidence is handled and presented for clinical review.
Focus Areas
Business Intelligence
| Technology | Cloud-native (EU-based processing), AI operating system (public read-only MCP interfaces for compatible AI agents), deterministic variant classification, evidence handling, phenotype-driven prioritization |
What Physicians Need to Know
For physicians, Helena Bioinformatics offers tools that streamline genomic variant interpretation by providing automated classification, comprehensive annotation, and source-linked evidence within a single workflow. This can significantly reduce the time and effort required for reviewing genomic findings. The 'Noodle' platform assists in quickly finding and exploring relevant biomedical literature, enhancing the understanding of complex cases. Their emphasis on human oversight in AI-assisted interpretation ensures that clinical judgment remains central to diagnosis and treatment decisions. The secure, EU-based processing of genomic data also addresses concerns about data privacy and sovereignty.
Helena Bioinformatics collaborates with laboratories, universities, and research organizations to build scientific, clinical, and commercial foundations for genomic interpretation. They have partnerships for whole-genome sequencing analysis and interpretation for clinical diagnostics, as well as with distributors for laboratory technology. They are also involved in research partnerships for intelligent biomedical systems, AI methods, and data-driven decision support, including connecting genomic data with robotics and automation.
Reviews & Opinions
Videos
News, demos, and interviews about Helena Bioinformatics.
Videos load interactively. If none appear, search YouTube for Helena Bioinformatics →
Press & Coverage
Frequently Asked Questions
Related Companies
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company that focuses on the discovery, development, and commercialization of prescription medicines. The company’s portfolio addresses major diseases in areas such as oncology, rare diseases, and biopharmaceuticals, which include cardiovascular, renal & metabolism, and respiratory & immunology. AstraZeneca operates globally, with a significant commercial presence in […]
Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Tempus AI, Inc. is an American health technology company that utilizes data and artificial intelligence to deliver precision medicine services. The company was founded with the mission to bring data-driven precision medicine into routine care, initially focusing on oncology. Tempus has developed a platform that sequences tumor samples and employs AI models to assist physicians […]

